50% of biopharma CEOs say they don't know what customers want; report

17 December 2019
boardroom-large-1-

It is generally recognized that the key to growth is understanding what customers want and delivering it in an exceptional way, but that’s not what is happening in the biopharma industry.

Now, a new  report from Accenture shows that, while biopharma chief executive officers (CEOs) increasingly hold their marketers accountable for anticipating and understanding customers to drive growth,  nearly half of biopharma marketing executives say they lack a good understanding of what customers want or need to manage their health.

That’s a serious disconnect, based on a survey of 40 biopharma CEOs and their marketing leaders and 4,000 patients in the USA, UK, France and Germany.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical